Home > Category > Signaling Pathways > Angiogenesis > VEGFR > Icrucumab (Anti-VEGFR1 / FLT1)

Icrucumab (Anti-VEGFR1 / FLT1)

ChemLeader 95+%
Catalog No:CLA1267 CAS No.:1024603-92-6 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $550.00 Visible after login
- +
5 mg 3-5days $1200.00 Visible after login
- +
10 mg 3-5days $1800.00 Visible after login
- +
50 mg 3-5days $6000.00 Visible after login
- +
100 mg 3-5days $12000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Icrucumab (Anti-VEGFR1 / FLT1)
CAS1024603-92-6
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Icrucumab (Anti-VEGFR1 / FLT1) is a humanized Anti-VEGFR-1 IgG1 monoclonal antibody, with potential anti-tumor and anti-metastatic agent. It also act as a therapeutic anti-angiogenic agent in different pathological contexts.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays